Last reviewed · How we verify
Listerine Experimental Mouthwash
Listerine Experimental Mouthwash kills oral bacteria and reduces plaque formation through its essential oil and antimicrobial active ingredients.
Listerine Experimental Mouthwash kills oral bacteria and reduces plaque formation through its essential oil and antimicrobial active ingredients. Used for Reduction of plaque and gingivitis, Halitosis (bad breath) control, General oral antimicrobial rinse.
At a glance
| Generic name | Listerine Experimental Mouthwash |
|---|---|
| Sponsor | Johnson & Johnson Consumer Inc. (J&JCI) |
| Drug class | Antimicrobial mouthwash |
| Modality | Small molecule |
| Therapeutic area | Oral Health / Dentistry |
| Phase | FDA-approved |
Mechanism of action
The mouthwash contains a combination of essential oils (eucalyptol, menthol, methyl salicylate, thymol) and other antimicrobial agents that disrupt bacterial cell membranes and inhibit microbial growth in the oral cavity. This reduces plaque accumulation, gingivitis, and halitosis by targeting pathogenic oral microorganisms.
Approved indications
- Reduction of plaque and gingivitis
- Halitosis (bad breath) control
- General oral antimicrobial activity
Common side effects
- Oral irritation or burning sensation
- Tooth staining
- Allergic reaction (rare)
Key clinical trials
- Clinical and Microbiological Comparison of 0.12% CHX and 0.05% CHX+0.05%CPC Mouthwashes in TPS Patients (NA)
- Determination of the Oral Irritation Potential of Two Alcohol-Free Rinses (NA)
- Anti-gingivitis Mouthrinse (PHASE3)
- A Two-Week Study of an Anticavity Low pH Mouthwash (PHASE4)
- A Clinical Study to Evaluate the Efficacy of a Range of Dental/Denture Products for Improved Oral Health in Partial Denture Wearers (PHASE4)
- A Study of Experimental Mouthwashes (PHASE4)
- Six Week Study of Experimental Mouth Rinses: Effect on Gingivitis and Plaque (PHASE1)
- A Twelve Week Study of Prototypes Mouth Rinses (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |